Merger and Acquisition (M&A) Trends in the Global Pharmaceutical and Biotechnology Industry

Merger and Acquisition (M&A) Trends in the Global Pharmaceutical and Biotechnology Industry

Increasing Volume and Decreasing Value

RELEASE DATE
09-Jan-2014
REGION
Global
Research Code: NBAE-01-00-00-00
SKU: LS00111-GL-MR_16952

$4,950.00

Special Price $3,712.50 save 25 %

In stock
SKU
LS00111-GL-MR_16952

$4,950.00

$3,712.50 save 25 %

DownloadLink

Pay by invoice

ENQUIRE NOW

Description

This research service analyzes merger and acquisition trends in the global pharmaceutical and biotechnology industry, along with specific merger and acquisition deals in this industry. Analysis is based on the number of and the average value of these deals. Merger and acquisition trends are also observed and analyzed based on the geographic region and buyer type. This research study delves into the nature of cross-border deals and also explores various deal multiples such as enterprise value, percent stakes sought, and target stock premium analysis of target companies. The study concludes with 5 big predictions.

Table of Contents

Preface

  • Title, Research Team, and Contents

Executive Summary

  • Executive Summary and Implications

Introduction

  • Introduction

The Key Rationale for M&A

  • Overview

Key M&A Statistics

  • Overview

Geographic Analysis

  • Overview

Cross-border Deal Analysis—Buyer’s Perspective for Asia-Pacific, Europe, and North America

  • Overview

Sectorial Analysis—Pharmaceutical

  • Overview

Sectorial Analysis—Biotechnology

  • Overview

Percent Stake Sought and Target Stock Premium Analysis

  • Overview

Conclusion

  • The 5 Big Conclusions

Appendix

  • Additional Information

The Frost & Sullivan Story

  • The Frost & Sullivan Story
Related Research
This study investigates the global stem cell market for the period 2013 to 2018. The geographic regions covered in the study are the North America, Europe and APAC, followed by a detailed Asia Pacific Region Analysis, which covers countries such as India, Australia, Thailand, Singapore, South Korea, Malaysia and Japan. The stem cell market is covered into four broad segments, namely by products, by technology and by application. The study covers various areas of interest such as regulatory policies within stem cell research, key business updates, analysis of risk factors, and strategic recommendations. Additionally, key clinical milestones, timelines of key clinical events, key companies to watch, and a strategic partnership assessment in the global stem cell market have been included.
More Information
No Index No
Podcast No
Author Saneesh Edacherian
WIP Number NBAE-01-00-00-00
Keyword 1 pharmaceutical
Keyword 2 biotechnology
Keyword 3 Merger and Acquisition
Is Prebook No